A new UCLA study reports that although metformin has proven to be effective in slowing the onset of diabetes, it is rarely prescribed for this purpose… The study, published in the peer-reviewed journal Annals of Internal Medicine, found that only 3.7 percent of U.S. adults with pre-diabetes were prescribed metformin …
Read More »Tolerance to Metformin through the Use of Gastrointestinal Microbiome
Gastrointestinal microbiome modulator may help alleviate the side effects of metformin and improve glucose control in patients with type 2 diabetes… Metformin’s main side effects are gastrointestinal and this limits the use of the medication either by not reaching the maximum dose or discontinued use altogether. The most common adverse …
Read More »The Gut’s Role When Using Metformin
New study sheds light on how metformin works to lower blood glucose… Metformin is the most widely used drug to treat type 2 diabetes, taken by 80 million users worldwide, but exactly how it works has remained unclear. The new study, which looked at metformin’s effects in rats, showed that …
Read More »Canagliflozin Versus Glimepiride in T2DM Patients Taking Metformin
Canagliflozin shows good results when compared to glimepiride in type 2 diabetes patients who were taking metformin.
Read More »Effects of Lifestyle Intervention and Metformin on the Development of Type 2 in Women With or Without GDM
Women with a history of GDM had 48% increased risk of developing diabetes… From previous studies it is known that women with gestational diabetes are at a higher risk for the development of type 2 diabetes. Previous results from the Diabetes Prevention Program (DPP) showed that Intensive Lifestyle Intervention (ILS) …
Read More »Intensive Lifestyle Weight-loss Intervention and Metformin in the Diabetes Prevention Program
In the DPP and DPP-OS trials, diabetes was prevented or delayed with metformin or ILS when directed at weight loss and increased physical activity… Previous randomized clinical trials such as the Diabetes Prevention Program and the long-term follow-up trial, the Diabetes Prevention Program Outcomes study, evaluated metformin and an intensive …
Read More »Lung Cancer Risk Reduction Seen in Nonsmokers on Metformin
But smokers taking the drug may have slightly increased risk…. Diabetic nonsmokers who had taken metformin had a decreased risk of lung cancer compared with metformin non-users, researchers said. A retrospective analysis covering 47,351 diabetic patients 40 and older found that, while metformin use was not associated with lower lung …
Read More »Linagliptin/Metformin Combination vs Linagliptin Monotherapy for Type 2 Diabetes
Earlier treatment for poorly controlled type 2 diabetes patients is advocated… Researchers from the University of Calgary, Alberta, Canada, evaluated glucose-lowering treatment strategies with linagliptin and metformin in people with newly diagnosed type 2 diabetes and marked hyperglycemia, a prevalent population for which few dedicated studies of oral antidiabetes drugs …
Read More »Acarbose Higher Cardiovascular Risk Than Metformin
According to a new retrospective study acarbose may not have a cardioprotective effect as good as metformin when used as first-line therapy… This study analyzed 17,366 patients who initiated acarbose therapy and 230,023 who initiated metformin therapy. Both nephropathy and diabetes complication severity index were strongly associated with the patients …
Read More »Metformin Has Positive Effect on Glucose Kinetics When Combined with Exercise
But the effects are modest and type 2 patients on metformin can do moderate exercise without undue fear of hypoglycemia… Before, during, and after a 45-min bout of exercise at 60% VO2max, glucose kinetics were determined by isotope tracer technique in patients with type 2 diabetes mellitus with metformin treatment …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.